Mouse sVCAM-1/CD106 Quantikine ELISA Kit

Name Mouse sVCAM-1/CD106 Quantikine ELISA Kit
Supplier R&D Systems
Catalog MVC00
Category ELISA Kit
Prices $479.00
Sizes 1 kit
Assay Type Solid Phase Sandwich ELISA
Sample Type Cell Culture Supernates (50 uL), Serum (10 uL), EDTA Plasma (10 uL)
Sensitivity 0.06 ng/mL
Range 0.3 - 20 ng/mL (Cell Culture Supernates, Serum, EDTA Plasma)
Format 96-well strip plate
Applications ELISA
Species Reactivities Mouse
Description The Quantikine Mouse soluble VCAM-1 Immunoassay is a 4.5 hour solid phase ELISA designed to measure mouse sVCAM-1 levels in cell culture supernates, serum, and EDTA plasma
Gene VCAM1
Supplier Page Shop

Product images


Product References

Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse - Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse

Grabmaier U, Kania G, Kreiner J, Grabmeier J, Uhl A, Huber BC, Lackermair K, Herbach N, Todica A, Eriksson U, Weckbach LT, Brunner S. PLoS One. 2016 Aug 8;11(8):e0158299.

A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil - A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil

Mishra A, Guo Y, Zhang L, More S, Weng T, Chintagari NR, Huang C, Liang Y, Pushparaj S, Gou D, Breshears M, Liu L. J Immunol. 2016 Oct 1;197(7):2828-37.

Reduction of adhesion molecule production and alteration of eNOS and endothelin-1 - Reduction of adhesion molecule production and alteration of eNOS and endothelin-1

Shih MF, Cherng JY. Molecules. 2014 Jul 18;19(7):10534-45.

Endothelial mineralocorticoid receptor activation enhances endothelial protein C - Endothelial mineralocorticoid receptor activation enhances endothelial protein C

Lagrange J, Li Z, Fassot C, Bourhim M, Louis H, Nguyen Dinh Cat A, Parlakian A, Wahl D, Lacolley P, Jaisser F, Regnault V. FASEB J. 2014 May;28(5):2062-72.

Early protection from burn-induced acute lung injury by deletion of - Early protection from burn-induced acute lung injury by deletion of

Sio SW, Moochhala S, Lu J, Bhatia M. Am J Respir Crit Care Med. 2010 Jan 1;181(1):36-46. doi:

Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung - Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung

Pfeiffer M, Hartmann TN, Leick M, Catusse J, Schmitt-Graeff A, Burger M. Br J Cancer. 2009 Jun 16;100(12):1949-56.

Early atherosclerosis and vascular inflammation in mice with diet-induced type 2 - Early atherosclerosis and vascular inflammation in mice with diet-induced type 2

Bartels ED, Bang CA, Nielsen LB. Eur J Clin Invest. 2009 Mar;39(3):190-9.

A neutralizing antibody against receptor for advanced glycation end products - A neutralizing antibody against receptor for advanced glycation end products

Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB. Atherosclerosis. 2008 Dec;201(2):274-80. doi:

Prevention of murine antiphospholipid syndrome by BAFF blockade. - Prevention of murine antiphospholipid syndrome by BAFF blockade.

Kahn P, Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Factor SM, Davidson A. Arthritis Rheum. 2008 Sep;58(9):2824-34.

Vascular dysfunction in a murine model of severe hemolysis. - Vascular dysfunction in a murine model of severe hemolysis.

Frei AC, Guo Y, Jones DW, Pritchard KA Jr, Fagan KA, Hogg N, Wandersee NJ. Blood. 2008 Jul 15;112(2):398-405.